Multiple Indicator Cluster Survey 2010
Eswatini, 2010
Get Microdata
Reference ID
SWZ_2010_MICS_v01_M
Producer(s)
United Nations Children’s Fund, Central Statistical Office
Collection(s)
Metadata
Created on
Jan 18, 2013
Last modified
Jul 18, 2018
Page views
151387
Downloads
2635
Times took SP / Fansidar (MN16)
Data file: wm
Overview
Valid:
25
Invalid:
4931
Type:
Discrete
Decimal:
0
Start:
123
End:
124
Width:
2
Range:
1 - 99
Format:
Numeric
Questions and instructions
Literal question
During this pregnancy, how many times did you take sp/ fansidar?
Categories
| Value | Category | Cases | |
|---|---|---|---|
| 1 | 10 |
40%
|
|
| 2 | 3 |
12%
|
|
| 3 | 6 |
24%
|
|
| 4 | 2 |
8%
|
|
| 5 | 1 |
4%
|
|
| 6 | 1 |
4%
|
|
| 9 | 1 |
4%
|
|
| 98 | DK | 1 |
4%
|
| 99 | Missing | 0 |
0%
|
| Sysmiss | 4931 |
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.
Interviewer instructions
Here we are asking about preventive doses of SP/Fansidar, not curative doses given if she had a fever. Therefore, in this question, we want to know only about preventive doses.
Record the number of times she took SP/Fansidar during pregnancy in the space provided. If the woman visited an antenatal clinic or other facility because she was sick with fever and was given SP/Fansidar, do not count this in the number of times she took SP/Fansidar during the pregnancy. Count only the 'times' taken (three tablets taken at the same time = '1 dose' = '1 time') when the woman was pregnant and did not have a fever.
Record the number of times she took SP/Fansidar during pregnancy in the space provided. If the woman visited an antenatal clinic or other facility because she was sick with fever and was given SP/Fansidar, do not count this in the number of times she took SP/Fansidar during the pregnancy. Count only the 'times' taken (three tablets taken at the same time = '1 dose' = '1 time') when the woman was pregnant and did not have a fever.
Description
Source of information
The eligible woman selected for interview